Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 22758-22759 [E9-11242]
Download as PDF
<![CDATA[
22758
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Notices
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
Exploratory Studies of Induced Pluripotent
Stem (IPS) Cells From Healthy & MH Patient
Populations.
Date: June 8, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Downtown, 1250
22nd Street, NW., Washington, DC 20037.
Contact Person: David W. Miller, PhD,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd, Room 6140, MSC 9608,
Bethesda, MD 20892–9608. 301–443–9734.
millerda@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: May 6, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11244 Filed 5–13–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
pwalker on PROD1PC71 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Centers for Behavioral Intervention
Development to Reduce Obesity (U01);
Date: June 1–2, 2009;
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Nov<24>2008
17:37 May 13, 2009
Jkt 217001
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: YingYing Li-Smerin, MD,
PhD, Scientific Review Officer, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7184, Bethesda, MD 20892–7924, 301–435–
0277, lismerin@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Research Demonstration and Dissemination
Projects (R18’s).
Date: June 2, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Holly K Krull, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7188,
Bethesda, MD 20892–7924, 301–435–0280,
krullh@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Pathway to Independence Award (K99’s).
Date: June 3, 2009.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Arlington Gateway, 801
North Glebe Road, Arlington, VA 22203.
Contact Person: Holly K Krull, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7188,
Bethesda, MD 20892–7924, 301–435–0280,
krullh@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Immunomodulatory, Inflammatory, and
Vasoregulatory Properties of Transfused Red
Blood Cell Units as a Function of Preparation
and Storage.
Date: June 8–9, 2009.
Time: 10 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: William J Johnson, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7178,
Bethesda, MD 20892–7924, 301–435–0725,
johnsonw@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Production Assistance for Cellular Therapies
(PACT) Program.
Date: June 11, 2009.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: The Westlin Baltimore Washington
Airport (BWI), 1110 Elkridge Landing Road,
Linthicum, MD 21090.
Contact Person: Katherine M Malinda,
PhD, Scientific Review Officer, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
7198, Bethesda, MD 20892–7924, 301–435–
0297, malindakm@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Coordinating Center to Administer the
NHLBI Production Assistance for Cellular
Therapies (PACT) Program.
Date: June 11, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: The Westlin Baltimore Washington
Airport (BWI), 1110 Old Elkridge Landing
Road, Linthicum, MD 20892.
Contact Person: Katherine M Malinda,
PhD, Scientific Review Officer, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7198, Bethesda, MD 20892–7924, 301–435–
0297, malindakm@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Exploratory Studies in the Neurobiology of
Pain in Sickle Cell Disease.
Date: June 12, 2009.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Youngsuk Oh, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7182,
Bethesda, MD 20892–7924, 301–435–0277,
yoh@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 7, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11243 Filed 5–13–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the nineteenth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
8:30 a.m. to approximately 5 p.m. on
Thursday, June 11, 2009, and from 8:30
a.m. to approximately 3 p.m. on Friday,
June 12, 2009, at the Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201.
E:\FR\FM\14MYN1.SGM
14MYN1
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Notices
pwalker on PROD1PC71 with NOTICES
The meeting will be open to the public
with attendance limited to space
available. The meeting also will be Web
cast.
At the meeting, the Committee will
continue its exploration of genetics and
the future health care system by hearing
presentations on anticipated changes in
health care and the role genetics and
genomics can play in achieving an
effective, affordable, and equitable
health care system. In addition, the
Committee will discuss its work on
genetics education and training and
consider a draft report on direct-toconsumer genomic services. Updates
will be provided as well on regulations
implementing the Genetic Information
Nondiscrimination Act and on the
Committee’s Public Consultation Draft
Report on Gene Patents and Licensing
Practices and Their Impact on Patient
Access to Genetic Tests.
As always, the Committee welcomes
hearing from anyone wishing to provide
public comment on any issue related to
genetics, health and society. Individuals
who would like to provide public
comment should notify the SACGHS
Executive Secretary, Ms. Sarah Carr, by
telephone at 301–496–9838 or e-mail at
carrs@od.nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite
750, Bethesda, MD 20892. Anyone
planning to attend the meeting who
needs special assistance, such as sign
language interpretation or other
reasonable accommodations, is also
asked to contact the Executive
Secretary.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
and genomic technologies and, as
warranted, to provide advice on these
issues. The draft meeting agenda and
other information about SACGHS,
including information about access to
the Web cast, will be available at the
following Web site: https://
oba.od.nih.gov/SACGHS/
sacghs_about.html.
Dated: May 7, 2009.
Jennifer Spaeth,
Director, NIH Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11242 Filed 5–13–09; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
17:37 May 13, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel. HIV Microbicides and
Prevention.
Date: May 20, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Adams Room, Rockville, MD
20852.
Contact Person: Eric Lorenzo, PhD,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616. 301–451–2640.
lorenzoe@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel. NIAID Science Education
Awards (R25).
Date: May 22, 2009.
Time: 9:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
(Telephone Conference Call).
Contact Person: Edward W. Schroder, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892. 301–435–8537.
eschroder@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group. Microbiology and Infectious Diseases
B Subcommittee.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
22759
Date: June 3, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Georgetown Suites, 1000 29th Street,
NW., Washington, DC 20007.
Contact Person: Gary S. Madonna, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID, National Institutes of Health, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892. 301–496–3528. gm12w@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel. Novel Diagnostics and
Therapeutics for Caliciviruses.
Date: June 3, 2009.
Time: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
(Telephone Conference Call).
Contact Person: Gregory P. Jarosik, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892. 301–496–0695.
gjarosik@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 6, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11239 Filed 5–13–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; ARRA
Competitive Supplements—Brain.
Date: June 5, 2009.
E:\FR\FM\14MYN1.SGM
14MYN1
]]>Agencies
[Federal Register Volume 74, Number 92 (Thursday, May 14, 2009)]
[Notices]
[Pages 22758-22759]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11242]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary's Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92-463, notice is hereby given of the
nineteenth meeting of the Secretary's Advisory Committee on Genetics,
Health, and Society (SACGHS), U.S. Public Health Service. The meeting
will be held from 8:30 a.m. to approximately 5 p.m. on Thursday, June
11, 2009, and from 8:30 a.m. to approximately 3 p.m. on Friday, June
12, 2009, at the Hubert H. Humphrey Building, 200 Independence Avenue,
SW., Washington, DC 20201.
[[Page 22759]]
The meeting will be open to the public with attendance limited to space
available. The meeting also will be Web cast.
At the meeting, the Committee will continue its exploration of
genetics and the future health care system by hearing presentations on
anticipated changes in health care and the role genetics and genomics
can play in achieving an effective, affordable, and equitable health
care system. In addition, the Committee will discuss its work on
genetics education and training and consider a draft report on direct-
to-consumer genomic services. Updates will be provided as well on
regulations implementing the Genetic Information Nondiscrimination Act
and on the Committee's Public Consultation Draft Report on Gene Patents
and Licensing Practices and Their Impact on Patient Access to Genetic
Tests.
As always, the Committee welcomes hearing from anyone wishing to
provide public comment on any issue related to genetics, health and
society. Individuals who would like to provide public comment should
notify the SACGHS Executive Secretary, Ms. Sarah Carr, by telephone at
301-496-9838 or e-mail at carrs@od.nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892. Anyone
planning to attend the meeting who needs special assistance, such as
sign language interpretation or other reasonable accommodations, is
also asked to contact the Executive Secretary.
Under authority of 42 U.S.C. 217a, Section 222 of the Public Health
Service Act, as amended, the Department of Health and Human Services
established SACGHS to serve as a public forum for deliberations on the
broad range of human health and societal issues raised by the
development and use of genetic and genomic technologies and, as
warranted, to provide advice on these issues. The draft meeting agenda
and other information about SACGHS, including information about access
to the Web cast, will be available at the following Web site: https://oba.od.nih.gov/SACGHS/sacghs_about.html.
Dated: May 7, 2009.
Jennifer Spaeth,
Director, NIH Office of Federal Advisory Committee Policy.
[FR Doc. E9-11242 Filed 5-13-09; 8:45 am]
BILLING CODE 4140-01-P
